Cancer Pharmacology and Computational Medicine
At Cancer Pharmacology and Computational Medicine we combine high-throughput screening, drug repurposing, innovative cell models, primary patient derived cells and computational approaches to find new treatment alternatives. We are also hosting the In vitro and systems pharmacology facility of the SciLife drug discovery and development (DDD) platform.
The research in Cancer Pharmacology is carried out by Professor Rolf Larsson, Professor Peter Nygren, Associate Professor Mårten Fryknäs, Associate professor Joachim Gullbo and Anna Segerman.
- Drug repositioning
- High-throughput screening – in 3D
- Targeting glioma
- Personalized medicine
- Targeting aminopeptidases for cancer therapy
- Sensitization of glioblastoma clones
The research in Computational Medicine is carried out by Professor Mats Gustafsson.
Equipment and compound libraries
The following technical equipment is available at the lab:
- Echo 550 acustic dispenser
- IncuCyte Zoom, FLR & HD
- SCARA analysis platform
- BioMek 4000
- Q Exactive mass spectrometer
- Cellomics ArrayScan
- EnSpire Multimode reader
- MagPix multiplex reader
- NucleoCounter NC-250
Chemical compound libraries
Number of compounds within brackets.
- Lopac (1280)
- Spectrum (2000)
- Pharmakon (1600)
- Selleckchem (1650)
- Actiprobe (2000)
- Maybridge hit kit (3000)
- Chembridge diverse set (10000)
- Enzo (800)